Actively Recruiting

Age: 6Years - 17Years
All Genders
NCT05849753

Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes

Led by Nemours Children's Clinic · Updated on 2026-02-23

50

Participants Needed

2

Research Sites

179 weeks

Total Duration

On this page

Sponsors

N

Nemours Children's Clinic

Lead Sponsor

J

Jaeb Center for Health Research

Collaborating Sponsor

AI-Summary

What this Trial Is About

50 children/adolescents (ages 6 to \<18yrs) with T1D in suboptimal control (HbA1c≥8.0%) and lower SES (below 200% poverty line) on insulin therapy (either injections or open-loop pumps) will be recruited at Nemours \~ 1/3 each AA, Hispanic/Latino, non-Hispanic whites. All families that qualify and agree to transition to closed-loop technologies will be recruited to allow data to be gathered before and after use of devices. They will go through the process of approval with the assistance of an insurance navigator in clinic. Those not a CGM will be prescribed one as well. Diabetes care will be 'real life', devices will be prescribed, and care per clinic routine with periodic device downloads. Principal outcome, time-in-range, will be analyzed at 3-months compared to baseline, each participant their own control. Secondary outcomes including HbA1c, other glucose metrics and questionnaires related to use of technology and diabetes distress will be also analyzed. All outcomes will also be collected at 6-months. Results could have important and fast applicability to the field and help better inform decision makers, including payers, clinicians, and patients and families and could serve to decrease health care disparities in this needy population.

CONDITIONS

Official Title

Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes

Who Can Participate

Age: 6Years - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of type 1 diabetes for at least 1 year based on clinical signs or positive diabetes autoantibodies and on insulin treatment (injections or open-loop pumps)
  • HbA1c of 8.0% or higher at least twice in the past 12 months, with an upper limit below 14%
  • Lower socioeconomic status defined as below 200% of the US poverty level by family size and income or exceptional circumstances per investigators
  • Approximately one-third African American, one-third Hispanic/Latino, and one-third non-Hispanic white; other ethnic groups allowed if criteria met
  • History of hypothyroidism is allowed if on adequate replacement therapy with normal thyroid function
Not Eligible

You will not qualify if you...

  • Severe eczema or other skin conditions that prevent wearing devices
  • Chronic medications or medical conditions that interfere with diabetes management (except ADHD medications)
  • Chronic seizures or severe neurodevelopmental delay
  • Current use of hybrid closed-loop or automated insulin delivery systems
  • Significant mental health disorders that would hinder device use as judged by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Nemours Children's Health

Jacksonville, Florida, United States, 32207

Actively Recruiting

2

Nemours Children's Health

Orlando, Florida, United States, 32827

Not Yet Recruiting

Loading map...

Research Team

N

Nelly Mauras, MD

CONTACT

K

Kelly Hildebrandt, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here